Related Experiment Video
Updated: Aug 9, 2026
06:28
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
Published on: June 4, 2020
Molecular recognition mechanisms of thrombin
1Department of Haematology, Cambridge Institute for Medical Research, Division of Structural Medicine, Thrombosis Research Unit, University of Cambridge, Cambridge, UK. jah52@cam.ac.uk
Journal of Thrombosis and Haemostasis : JTH
|August 17, 2005
Summary
Thrombin, a key enzyme in blood clotting, uses its active site and exosites to recognize and bind substrates. Recent studies reveal how these features, often involving cofactors, drive molecular recognition crucial for hemostasis.
Area of Science:
- Biochemistry
- Structural Biology
- Hemostasis
Background:
- Thrombin is the terminal protease in blood coagulation, essential for fibrin clot formation.
- Unlike other coagulation proteases, thrombin possesses only a serine protease domain, enabling free diffusion and interaction with numerous substrates.
- Thrombin plays diverse roles in hemostasis by cleaving over a dozen substrates.
Purpose of the Study:
- To summarize recent biochemical and structural data on thrombin's substrate recognition.
- To elucidate the molecular determinants governing thrombin-substrate interactions.
- To provide insight into the molecular recognition events critical for hemostasis.
Main Methods:
- Analysis of thrombin mutant libraries.
- Examination of crystal structures of thrombin and its complexes.
- Biochemical assays to study enzyme-substrate interactions.
Main Results:
- Thrombin's deep active site cleft and two adjacent basic exosites are critical for substrate recognition.
- Both exosites are typically involved in substrate binding, either directly or indirectly via cofactors.
- Recent structural and mutagenesis data provide a comprehensive view of thrombin's molecular recognition mechanisms.
Conclusions:
- Thrombin utilizes its unique structural features, including exosites, for specific substrate binding.
- Molecular recognition by thrombin, often involving cofactors, is central to its role in hemostasis.
- Ongoing research continues to refine our understanding of these complex molecular interactions.
More Related Videos
Related Concept Videos
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:09Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.